🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The episode you've all been waiting for... Dr. Alaina Jaster, PhD & Jack Gorsline break down the DEA hearing for ya'll big style. #psychedelicbrainscience #DEAhearing #keeppsychedelicresearchlegal #ssdp #sciencepolicy #psychedelics #psychedelicresearch open.spotify.com/episode/1fpbzT…

Interviews: Meet the Team Who Challenged the DEA on DOI and DOC Alaina Jaster, PhD profiles the scientists, advocates, and lawyers challenging the agency's proposed scheduling of two phenethylamine psychedelics. psychedelicalpha.com/news/interview…

Happy to be able to spotlight some of the coolest people I know! My latest feature for Psychedelic Alpha psychedelicalpha.com/news/interview…

Psychedelics investors are very worried about reg. and legislative barriers to approval, mainly in response to FDA's Lykos verdict and slow state-level progress. Safety & Ethics concerns are a new category identified in this latest survey. More... psychedelicalpha.com/news/q324-surv…

"thanks so much for the feedback"

Best of luck to all submitting grad school apps this cycle! It’s been a privilege to support some amazing folks ☀️ PLEASE remember that your worth is NOT dependent on the outcome — it’s truly so subjective & there will ALWAYS be more chances. You deserve rest & celebration! 🙌🏾🫶🏾

Structural insights into tryptamine psychedelics: The role of hydroxyl indole ring site in 5-HT2A receptor activati… pubmed.ncbi.nlm.nih.gov/39541872/

Our final episode in the #psychedelic circuitry series!! And maybe the year?? This episode dives into threat, amygdala, PVN + how psychedelics alter these responses in male and females animal models! Featuring the great Devin Effinger, PhD! psychedelicbrainscience.com/podcast/episod…

New publication from CPCR Faculty Albert Garcia-Romeu, Sandeep Nayak (Sandeep Nayak), Nathan Sepeda (Nate Sepeda), and colleagues! sciencedirect.com/science/articl…

The never-ending millennial struggle to refrain from ending a sentence in an email with “lol” is EXHAUSTING.

Animal researchers - Is drug discrimination still considered the golden standard for assessing abuse liability in 2024?

When writing a paper or doing an analysis would you say it’s important to include data published in the last 5 years leading up to your publication?

My latest, via Filter | harm reduction journalism! Honored to be able to expand my coverage back to my home state — I grew up less than an hour from Louisa County and hope to interview Dawn Morris in person before she’s sentenced in February.

How do we live better knowing we will someday die? 💀 Alex Sielaff, PhD, dives into existential psychology and explores how psychs, breathwork, and other out there experiences might (or might not) help us live more meaningful lives. 🌌 open.spotify.com/episode/2W0ZEf…

how it feels sending work emails in december

What are your favorite or least favorite psychedelic moments this year? Most standout events/papers/talks? Let us know!!

SSDP's Drug Education Committee is hard at work revamping our Just Say Know curriculum to provide comprehensive, unbiased, and evidence-based drug education for students and youth across the country. We need your help to make it happen here: buff.ly/4iEWEz3

Thank you for asking. You seem serious. Yes, patient access is important. This isn't about access. Mindbloom is introducing people to minimally supervised injectable ketamine. This is a public health experiment. A few comments: